Wang Wei, Jittikanont Suparoek, Falk Sandor A, Li Ping, Feng Lili, Gengaro Patricia E, Poole Brian D, Bowler Russell P, Day Brian J, Crapo James D, Schrier Robert W
Department of Medicine, University of Colorado Health Sciences Center, Denver 80262, USA.
Am J Physiol Renal Physiol. 2003 Mar;284(3):F532-7. doi: 10.1152/ajprenal.00323.2002.
Acute renal failure (ARF) during sepsis is associated with increased nitric oxide (NO) and oxygen radicals, including superoxide (O(2)(-)). Because O(2)(-) reacts with NO in a rapid manner, it plays an important role in modulating NO levels. Therefore, scavenging of O(2)(-) by superoxide dismutase (SOD) may be critical for preserving NO bioavailability. In mice, substantial renal extracellular SOD (EC-SOD) expression implies its important role in scavenging O(2)(-) in the kidney. We hypothesized that during endotoxemic ARF, EC-SOD is decreased in the kidney, resulting in increased O(2)(-) and thus decreased vascular NO bioavailability with resultant renal vasoconstriction and ARF. In the present study, normotensive endotoxemic ARF was induced in mice using lipopolysaccharide (LPS; 5 mg/kg ip). Sixteen hours after LPS, glomerular filtration rate (GFR; 50 +/- 16 vs. 229 +/- 21 microl/min, n = 8, P < 0.01) and renal blood flow (RBF; 0.61 +/- 0.10 vs. 0.86 +/- 0.05 ml/min, n = 8, P < 0.05) were subsequently decreased. EC-SOD mRNA and protein expression in endotoxemic kidneys were decreased at 16 h compared with controls. A catalytic antioxidant, metalloporphyrin, reversed the deleterious effects of endotoxemia on renal function as GFR (182 +/- 40 vs. 50 +/- 16 microl/min, n = 6, P < 0.01) and RBF (1.08 +/- 0.10 vs. 0.61 +/- 0.10 ml/min, n = 6, P < 0.05) were preserved. Similar results were obtained with tempol, a chemically dissimilar antioxidant. Specific inhibition of inducible nitric oxide synthase (iNOS), l-N(6)-(1-iminoethyl)-lysine, reversed the renal protective effect on GFR and RBF observed with antioxidant treatment during endotoxemia. In summary, renal EC-SOD expression is decreased during endotoxemia. Antioxidant therapy preserved GFR and RBF during endotoxemia. The reversal of this protective effect by inhibition of iNOS suggests the importance of the bioavailability of NO for preservation of renal function during early endotoxemia.
脓毒症期间的急性肾衰竭(ARF)与一氧化氮(NO)及氧自由基(包括超氧阴离子(O₂⁻))增加有关。由于O₂⁻能迅速与NO反应,它在调节NO水平中起重要作用。因此,超氧化物歧化酶(SOD)清除O₂⁻可能对维持NO生物利用度至关重要。在小鼠中,大量肾细胞外SOD(EC-SOD)表达提示其在清除肾脏中O₂⁻方面的重要作用。我们推测在内毒素血症性ARF期间,肾脏中EC-SOD减少,导致O₂⁻增加,进而血管NO生物利用度降低,引起肾血管收缩和ARF。在本研究中,使用脂多糖(LPS;5 mg/kg腹腔注射)诱导小鼠发生正常血压的内毒素血症性ARF。LPS注射16小时后,肾小球滤过率(GFR;50±16 vs. 229±21微升/分钟,n = 8,P < 0.01)和肾血流量(RBF;0.61±0.10 vs. 0.86±0.05毫升/分钟,n = 8,P < 0.05)随后降低。与对照组相比,内毒素血症肾脏中EC-SOD mRNA和蛋白表达在16小时时降低。一种催化性抗氧化剂金属卟啉可逆转内毒素血症对肾功能的有害影响,GFR(182±40 vs. 50±16微升/分钟,n = 6,P < 0.01)和RBF(1.08±0.10 vs. 0.61±0.10毫升/分钟,n = 6,P < 0.05)得以维持。与tempol(一种化学性质不同的抗氧化剂)得到了相似结果。诱导型一氧化氮合酶(iNOS)的特异性抑制剂L-N⁶-(1-亚氨基乙基)-赖氨酸可逆转内毒素血症期间抗氧化剂治疗所观察到的对GFR和RBF的肾保护作用。总之,内毒素血症期间肾脏EC-SOD表达降低。抗氧化剂治疗在内毒素血症期间维持了GFR和RBF。抑制iNOS使这种保护作用逆转,提示在内毒素血症早期,NO生物利用度对维持肾功能的重要性。